US2004197844A1PendingUtilityA1
Marker for inflammatory conditions
Est. expiryJan 12, 2021(expired)· nominal 20-yr term from priority
G01N 33/5091C07K 14/4715G01N 33/564G01N 33/689G01N 33/6893G01N 2800/324G01N 2800/368
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Use of pregnancy-associated plasma protein-A as a marker for inflammatory conditions, and in particular, for acute coronary syndromes is described.
Claims
exact text as granted — not AI-modified1 - 12 . (canceled)
13 . An article of manufacture for diagnosing an inflammatory condition in a non-pregnant patient, said article of manufacture comprising an anti-PAPP-A antibody and packaging material, wherein said anti-PAPP-A antibody can be used for measuring PAPP-A levels in a biological sample from said patient, and wherein said packaging material comprises a label or package insert indicating that said anti-PAPP-A antibody can be used for diagnosing said inflammatory condition.
14 . The article of manufacture of claim 13 , wherein said biological sample is selected from the group consisting of whole blood, plasma, and serum.
15 . An article of manufacture for diagnosing an inflammatory condition in a non-pregnant patient, said article of manufacture comprising reagents for measuring levels of a plurality of polypeptides in a biological sample from said patient, wherein said plurality of polypeptides comprises PAPP-A and one or more of the polypeptides selected from the group consisting of high sensitivity C-reactive protein, creatine kinase MB, troponin I, troponin T, creatine kinase, creatinine, fibrinogen, interleukin-1, and interleukin-6.
16 . The article of manufacture of claim 15 , wherein said biological sample is selected from the group consisting of whole blood, plasma, and serum.
17 - 22 . (canceled)Join the waitlist — get patent alerts
Track US2004197844A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.